Tower Research Capital LLC (TRC) - VINCERX PHARMA INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$7,250
+33.7%
7,178
+72.1%
0.00%
Q2 2023$5,423
+180666.7%
4,172
+41.4%
0.00%
Q1 2023$30.0%2,950
+10.9%
0.00%
Q4 2022$32,661
+6235.7%
0.00%
Q3 2022$0
-100.0%
42
-99.4%
0.00%
Q2 2022$9,000
-10.0%
6,758
+174.0%
0.00%
Q1 2022$10,000
-16.7%
2,466
+106.7%
0.00%
Q4 2021$12,000
+20.0%
1,193
+93.4%
0.00%
Q3 2021$10,000617
+1769.7%
0.00%
Q2 2021$0
-100.0%
33
-80.4%
0.00%
Q1 2021$3,0001680.00%
Other shareholders
VINCERX PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,658,199$2,189,0000.84%
Affinity Asset Advisors, LLC 1,374,098$1,814,0000.76%
SABBY MANAGEMENT, LLC 500,559$661,0000.45%
TANG CAPITAL MANAGEMENT LLC 1,030,634$1,360,0000.21%
Rubric Capital Management LP 2,107,000$2,781,0000.15%
Long Focus Capital Management, LLC 980,000$1,294,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$508,0000.09%
Clearline Capital LP 452,184$597,0000.08%
Sio Capital Management, LLC 102,049$135,0000.05%
Rock Springs Capital Management LP 814,194$1,075,0000.03%
View complete list of VINCERX PHARMA INC shareholders